Pharmacology and mechanisms of opioid analgesic activity

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 1 II, 1997, Pages 94-111

  Yaksh, T L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

analgesia; bulbospinal pathway; delta receptors; kappa receptors; mu receptors; opiate receptors; periaqueductal gray; rostral ventral medulla; spinal cord; substantia nigra

Indexed keywords

BETA FUNALTREXAMINE; BREMAZOCINE; BUTORPHANOL; DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; NALTRINDOLE; OPIATE; OPIATE RECEPTOR; PETHIDINE; SPIRADOLINE; SUFENTANIL;

ANALGESIA; ANALGESIC ACTIVITY; ANTINOCICEPTION; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; HUMAN; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; SUBSTANTIA NIGRA;

EID: 0031033162     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04623.x     Document Type: Conference Paper

References (183)

1. Martin WR, Eades CG, Thompson WO, Thompson JA, Flanary HG. Morphine physical dependence in the dog. J Pharmacol Exp Ther 1974: 189: 759-771.
2. Lord JA, Waterfield AA, Hughes J, Kosterlitz HW. Endogenous opioid peptides: multiple agonists and receptors. Nature 1977: 267: 495-499.
3. Chen Y, Mestek A, Liu J, Hurley JA, Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol 1993: 44: 8-12.
4. Thompson RC, Mansour A, Akil H, Watson SJ. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 1993: 11: 903-913.
5. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci USA 1992: 89: 12048-12052.
6. Chen Y, Mestek A, Liu J, Yu L. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J 1993: 295: 625-628.
7. Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B, Liu-Chen LY. Molecular cloning and expression of a rat kappa opioid receptor. Biochem J 1993: 295: 629-633.
8. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci USA 1993: 90: 9954-9958.
9. Uhl GR, Childers S, Pasternak G. An opiate-receptor gene family reunion. Trends Neurosci 1994: 17: 89-93.
10. Pasternak GW. Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 1993: 16: 1-18.
11. Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F. Differential antagonism of opioid delta antinociception by [D-ala2,Leu5, Cys6] - enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther 1991: 257: 1069-1075.
12. Hammond DL, Stewart PE, Littell L. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone. J Pharmacol Exp Ther 1995: 274: 1317-1324.
13. Stewart PE; Hammond DL. Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther 1994: 268: 701-708.
14. Yoshimura M, North RA. Substantia gelatinosa neurones in vitro hyperpolarised by enkephalin. Nature 1983: 305: 529-530.
15. Grudt TJ, Williams JT. Kappa-Opioid receptors also increase potassium conductance. Proc Natl Acad Sci USA 1993: 90: 11429-11432.
16. Carter BD, Medzihradsky F. Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Proc Natl Acad Sci USA 1993: 90: 4062-4066.
17. Kaneko S, Fukuda K, Yada N, Akaike A, Mori Y, Satoh M. Ca2+ channel inhibition by kappa opioid receptors expressed in Xenopus oocytes. Neuroreport 1994: 5: 2506-2508.
18. Piros ET, Prather PL, Loh HH, Law PY, Evans CJ, Hales TG. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells. Mol Pharmacol 1995: 47: 1041-1049.
19. Shen K-F, Crain SM. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res 1989: 491: 227-242.
20. Yaksh TL, Rudy TA Chronic catheterization of the spinal subarachnoid space. Phys Behav 1976: 17: 1031-1036.
21. Manning BH, Morgan MJ, Franklin KB. Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. Neuroscience 1994: 63:289-294.
22. Yaksh TL, Yeung JC, Rudy TA. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: Observation of differential effect within the periaqueductal gray. Brain Res 1976: 114: 83-103.
23. Sharpe LG, Garnett JE, and Cicero TJ. Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. Behav Biol 1974: 11: 303-313.
24. Criswell HD. Analgesia and hypereactivity following morphine microinjections into mouse brain. Pharmacol Biochem Behav 1976: 4: 23-26.
25. Ossipov MH, Goldstein FJ, Malseed RT. Feline analgesia following central administration of opioids. Neuropharmacology 1984: 23: 925-929.
26. Wettstein JG, Kamerling SG, Martin WR. Effects of microinjections of opioids into and electrical stimulation (ES) of the canine periaqueductal gray (PAG) on electrogenesis (EEG), heart rate (HR), pupil diameter OPD), behavior and analgesia. Neurosci Abstr 1982: 8: 229.
27. Pert A, Yaksh TL. Sites of morphine induced analgesia in the primate brain: relation to pain pathways. Brain Res 1974: 80: 135-140.
28. Pert A, Yaksh TL. Localization of the antinociceptive action of morphine in primate brain. Pharmacol Biochem Behav 1975: 3: 133-138.
29. Kasman GS, Rosenfeld JP. Opiate microinjections into midbrain do not affect the aversiveness of caudal trigeminal stimulation but produce somatotopically organized peripheral hypoalgesia. Brain Res 1986: 383: 271-278.
30. Yaksh TL, Al-Rodhan NRF, Jensen TS. Sites of action of opiates in production of analgesia. Prog Brain Res 1988: 77: 371-394.
31. Fedynyshyn JP, Kwiat G, Lee N. Characterization of high affinity opioid binding sites in rat periaqueductal gray P2 membrane. Eur J Pharmacol 1989: 159: 83-88.
32. Fedynyshyn JP, Lee NM. Mu type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to G-protein-mediated inhibition of adenylyl cyclase. FEBS Letters 1989: 253: 23-27.
33. 2] metenkephalinamide and morphine in the mesencephalic reticular formation of rats. Life Sci 1978: 23: 1229-1240.
34. Jensen TS, Yaksh TL. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res 1986: 372: 301-312.
35. Satoh M, Oku R, Akaike A. Analgesia produced by microinjection of L-glutamate into the rostral ventromedial bulbar nuclei of the rat and its inhibition by intrathecal α-adrenergic blocking agents. Brain Res 1983: 261: 361-364.
36. Baumeister AA, Hawkins MF, Anticich TG, Moore LL, Higgins TD, Vaughn A, Chatellier MO. Bilateral intranigral microinjection of morphine and opioid peptides produces antinociception in rats. Brain Res 1987: 411: 183-186.
37. Baumeister AA, Nagy M, Hebert G, Hawkins MF, Vaughn A, Chatellier MO. Further studies of the effects of intra nigral morphine on behavioral responses to noxious stimuli. Brain Res 1990: 525: 115-125.
38. Baumeister AA. The effects of bilateral intranigral microinjection of selective opioid agonists on behavioral responses to noxious thermal stimuli. Brain Res 1991: 557: 136-145.
39. Tseng LF, Wang Q. Forebrain sites differentially sensitive to beta-endorphin and morphine for analgesia and release of Met-enkephalin in the pentobarbital-anesthetized rat. J Pharmacol Exp Ther 1992: 261: 1028-1036.
40. Ma QP, Han JS. Neurochemical and morphological evidence of an antinociceptive neural pathway from nucleus raphe dorsalis to nucleus accumbens in the rabbit. Brain Res Bull 1992: 28: 931-936.
41. d'Amore A, Lorenzini P, Massotti M. Antinociceptive action of opiates and opioid peptides after unilateral microinjection into area tempestas in rats. J Pharmacol Exp Ther 1991: 259: 1308-1315.
42. Rodgers RJ. Elevation of aversive threshold in rats by intra amygdaloid injection of morphine sulfate. Pharmacol Biochem Behav 1977: 6: 385-390.
43. Prado WA. Antinociceptive effect of agonists microinejcted into the anterior pretectal nucleus of the rat. Brain Res 1989: 493: 145-154.
44. Yaksh TL, and Malmberg AB. Central pharmacology of nociceptive transmission. In: Wall P, Melzack R,eds. Textbook of Pain 3. ed. Edinburgh: Churchil Livingstone, 1994: 165-200.
45. Yaksh TL, and Malmberg AB. Interaction of spinal modulatory receptor systems. In: Fields HL, Liebeskind JC, eds. Progress in Pain Research and Management, Vol. 1. Seattle: IASP Press, 1994: 151-171
46. Gebhart GF, Sandkuhler J, Thalhammer J and Zimmerman M. 1984. Inhibition in spinal cord of nociceptive information by electrical stimulation and morphine microinjections at identical sites in midbrain of the cat. J Neurophysiol 1984: 51: 75-89.
47. Gebhart GF, Jones SL. Effects of morphine given in the brainstem on the activity of dorsal horn nociceptive neurons. Prog Brain Res 1988: 77: 229-243.
48. Reddy SVR, Maderdrut JL, Yaksh TL. Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther 1980: 213: 525-533.
49. Takano Y, and Yaksh TL. Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther 1992: 261: 764-772.
50. Yaksh TL, Wilson PR. Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther 1979: 208: 446-453.
51. 3 receptor subtypes modulate responses to noxious colorectal distention in the rat. Brain Res 1991: 538: 64-75.
52. El-Yassir N, Fleetwood-Walker SM, Mitchell R. Heterogeneous effects of serotonin in the dorsal horn of rat: the involvement of 5-HT1 receptor subtypes. Brain Res 1988: 456: 147-58.
53. Nakagawa I, Omote K, Kitahata LM, Collins JG, Murata K. Serotonergic mediation of spinal analgesia and its interaction with noradrenergic systems. Anesthesiology 1990: 73: 474-478.
54. Fleetwood-Walker SM, Mitchell R, Hope PJ, Molony V, Iggo A. An alpha-2 receptor mediates the selective inhibition by noradrenaline of nociceptive responses of identified dorsal horn neurones. Brain Res 1985: 334: 243-254.
55. Yaksh TL, and Tyce GM. Microinjection of morphine into the periaqueductal gray evokes the release of serotonin from spinal cord. Brain Res 1979: 171: 176-181.
56. Takagi H, Shiomi H, Kuraishi Y, Fukui K, Ueda H. Pain and the bulbospinal noradrenergic system: Pain-induced increase in normetanephrine content in the spinal cord and its modification by morphine. Eur J Pharmacol 1979: 54: 99-107.
57. Yaksh TL. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 1979: 160: 180-185.
58. Camarata PJ, Yaksh TL. Characterization of the spinal adrenergic receptors mediating the spinal effects produced by the microinjection of morphine into the periaqueductal gray. Brain Res 1985: 336: 133-142.
59. Renno WM, Mullett MA, Beitz AJ. Systemic morphine reduces GABA release in the lateral but not the medial portion of the midbrain periaqueductal gray of the rat. Brain Res 1992: 594: 221-232.
60. Ehbehani MM, Jiang MR, Chandler SD, Ennis M. The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat. Pain 1990: 40: 195-204.
61. Mohrland S, Gebhart G. Effects of focal electrical stimulation and morphine microinjection in the periaqueductal gray of the rat mesencephalon on neuronal activity in the medullary reticular formation. Brain Res 1980: 201: 23-37.
62. Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory circuits. Ann Rev Neurosci 1991: 14: 219-245.
63. Ramberg DA, Yaksh TL. Effects of cervical spinal hemisection of dihydromorphine binding in brainstern and spinal cord in cat. Brain Res 1989: 483: 61-67.
64. Ma QP, Yin GF, Ai MK, Han JS. Serotonergic projections from the nucleus raphe dorsalis to the amygdala in the rat. Neurosci Lett 1991: 134: 21-24.
65. Amaral DG, Sinnamon HM. The locus ceruleus: Neurobiology of a central noradrenergic nucleus. Prog Neurobiol 1977: 9: 147-196.
66. Samanin R, Gumulka W, Valzelli L. Reduced effect of morphine in midbrain raphe lesioned rats. Exr J Pharmacol 1970: 10: 339.
67. Yaksh TL, Rudy TA. Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther 1977: 202: 411-428.
68. Tenen SS. Antagonism of the analgesic effect of morphine and other drugs by p-chlorophenylalanine, a serotonin depletor. Psychopharmacology 1968: 12: 278.
69. Hylden JLK, Wilcox GL. Pharmacological, characterization of substance P induced nociception in mice: Modulation by opioid and noradrenergic agonists at the spinal level. J Pharmacol Exp Ther 1983: 226: 398-404.
70. Yaksh TL, Rudy TA. Analgesia mediated by a direct spinal action of narcotics. Science 1976: 192: 1357-1358.
71. Yaksh TL. Analgetic actions of intrathecal opiates in cat and primate. Brain Res 1978: 153: 205-210
72. Tung AS, Yaksh TL. The antinociceptive effects of epidural opiates in the cat: studies on the pharmacology and the effects of lipophilicity in spinal analgesia. Pain 1982: 12: 343-356.
73. Sabbe MB, Grafe MR, Mjanger E, Tiseo PJ, Hill HF, Yaksh TL. Spinal delivery of sufentanil, alfentanil and morphine in dogs. Physiologic and toxicologic investigations. Anesthesiology 1994: 81: 899-920.
74. Yaksh TL, Reddy SVR. Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen. Anesthesiology 1981: 54: 451-467.
75. Yaksh TL. In vivo studies on spinal opiate receptor systems mediating antinociception. Mu and delta receptor profiles in the primate. J Pharmacol Exp Ther 1983: 226: 303-316.
76. Yaksh TL, Pogrel JW, Lee YW, Chaplan SR. Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoreceptor agonists. J Pharmacol Exp Ther 1995: 272: 207-214.
77. Schmauss C, Yaksh TL. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 1984: 228: 1-12.
78. Yaksh TL, Noueihed R. The physiology and pharmacology of spinal opiates. Ann Rev Pharmacol Toxicol 1985: 25: 433-462.
79. Malmberg AB, and Yaksh TL. Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: Effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther 1992: 263: 264-275.
80. Stewart PE, Holper EM, Hammond DL. Delta antagonist and kappa agonist activity of Naltriben: evidence for differential kappa interaction with the delta-1 and delta-2 opioid receptor subtypes. Life Sci 1994: 55: 79-84.
81. Yaksh TL, Gross KE, Li CH. Studies on the intrathecal effect of β-endorphin in primate. Brain Res 1982: 241: 261-269.
82. Calvillo O, Henry JL, Neuman RS. Effects of morphine and naloxone on dorsal horn neurones in the cat. Can J Physiol Pharmacol 1974: 52: 1207-1211.
83. Fleetwood-Walker SM, Mitchell R, Hope PJ, El-Yassir N, Molony V, Bladon CM. The involvement of neurokinin receptor subtypes in somatosensory processing in the superficial dorsal horn of the cat. Brain Res 1990: 519: 169-182.
84. Le Bars D, Menétrey D, Conseiller C, Besson JM. Depressive effects of morphine upon lamina V cells activities in the dorsal horn of the spinal cat. Brain Res 1975: 98: 261-277.
85. Yaksh TL. Inhibition of etorphine of the discharge of dorsal horn neurons: Effects upon the neuronal response to the both high- and low-threshold sensory input in the decerebrate spinal cat. Exp Neurol 1978: 60: 23-40.
86. Glaum SR, Miller RJ, Hammond DL. Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord. J Neurosci 1994: 14: 4965-1971.
87. Gouardères C, Cros J, Quirion R. Autoradiographic localization of μ, ∂ and κ opioid receptor binding sites in rat and guinea pig spinal cord. Neuropeptides 1985: 5: 331-342.
88. Morris BJ, Herz A. Distinct distribution of opioid receptor types in rat lumbar spinal cord. Naunyn-Schmiedeberg's Arch Pharmacol 1987: 336: 240-243.
89. 3H]DPDPE in the spinal cord of sheep. Advances Biosciences 1989: 75: 289.
90. Stevens CW, Lacey CB, Miller KE, Eide RP, Seybold VS. Biochemical characterization and regional quantification of mu, delta and kappa opioid binding sites in rat spinal cord. Brain Res 1991: 550: 77-85.
91. Besse D, Lombard M-C, Zajac J-M, Roques BP, Besson J-M. Pre- and postsynaptic location of mu, delta and kappa opioid receptors in the superficial layers of the dorsal horn of the rat spinal cord. In: International Narcotics Research Conference (INRC). Alan R. Liss, Inc. 1990: 182.
92. Stevens CW, Seybold VS. Changes of opioid binding density in the rat spinal cord following unilateral dorsal rhizotomy. Brain Res 1995: 687: 53-62.
93. Fields'HL, Emson PC, Leigh BK, Gilbert RFT, Iverses LL. Multiple opiate receptor sites on primary afferent fibres. Nature 1980: 284: 351-353.
94. Yaksh TL, Jessell TM, Gamse R, Mudge AW, Leeman SE. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 1980: 286: 155-156.
95. Go VL, Yaksh TL. Release of substance P from the cat spinal cord. J Physiol Land 1987: 391: 141-167.
96. Hirota N, Kuraishi Y, Hino Y, Sato Y, Satoh M, Takagi H. Met-enkephalin and morphine but not dynorphin inhibit the noxious stimuli-induced release of substance P from rabbit dorsal horn in situ. Neuropharmacol 1985: 24: 567-570.
97. Aimone LD, Yaksh TL. Opioid modulation of capsaicinevoked release of substance P from rat spinal cord in vivo. Peptides 1989: 10: 1127-1131.
98. Bourgoin S, Benoliel JJ, Collin E, Mauborgne A, Pohl M, Hamon M, Cesselin F. Opioidergic control of the spinal release of neuropeptides. Possible significance for the analgesic effects of opioids. Fund Clin Pharmacol 1994: 8: 307-321.
99. Zieglgänsberger W, Bayerl H. The mechanism of inhibition of neuronal activity by opiates in the spinal cord of cat. Brain Res 1976: 115: 111-128.
100. Cahill CM, White TD, Sawynok J. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes. J Pharmacol Exp Ther 1995: 275: 84-93.
101. 2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord. J Pharmacol Exp Ther 1989: 250: 915-922.
102. + stimulated release of substance P from rat spinal cord slices. Society Neurosci Abstr 1986: 12: 799.
103. Gissen AJ, Gugino LD, Datta S, Miller J, Covino BG. Effects of fentanyl and sufentanil on peripheral mammalian nerves. Anesth Analg 1987: 66: 1272-1276.
104. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A: Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 1989: 248: 1269-1275.
105. Nagasaka H, Yaksh TL. Peripheral and spinal actions of opioids in the blockade of the autonomic response evoked by compression of the inflamed knee joint. Anesthesiology 1995, in press.
106. Stein CS: Peripheral mechanism of opioid analgesia. Anesth Analg 1993: 76: 182-191.
107. Laduron PM. Axonal transport of opiate receptors in capsaicin-sensitive neurones. Brain Res 1984: 294: 157-160.
108. Yaksh TL: Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 1988: 458: 319-324.
109. Russell NJW, Schaible H-G, Schmidt RF. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat. Neurosci Lett 1987: 76: 107-112.
110. Andreev N, Urban L, Dray A. Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation. Neuroscience 1994: 58: 793-798.
111. Tsou K. Antagonism of morphine analgesia by the intracerebral microinjection of nalorphine. Acta Physiologica Sinica 1963: 26: 332-337.
112. Vigouret J, Tesechemacher H, Albus K, Herz A. Differentiation between spinal and supraspinal sites of action of morphine when inhibiting the hind limb flexor reflex in rabbits. Neuropharmacology 1973: 12: 111-121.
113. Yaksh TL, Rudy TA. Narcotic analgesics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 1978: 4: 299-359.
114. Yeung JC, Rudy TA. Multiplicative interaction between narcotic agonism expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventriuclar injections of morphine. J Pharmacol Exp Ther 1980: 215: 633-642.
115. Roerig SC, Fujimoto JM. Multiplicative interaction between intrathecally and intracerebroventricularlyadministered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice. J Pharmacol Exp Ther 1989: 249: 762-768.
116. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 1989: 45: 947-961.
117. Bodnar R, Paul D, Pasternak GW. Synergistic analgesic interactions between the periaqueductal gray and the locus coeruleus. Brain Res 1991: 558: 224-230.
118. Xia LY, Huang KH, Rosenfeld JP. Behavioral and trigeminal neuronal effects of rat brainstem-nanoinjected opiates. Physiol Behav 1992: 52: 65-73.
119. 2-adrenergic agonists as analgesics. In: Aitkenhead AR, Benad G, Brown BR, Cousins MC, Jones JG, Strunin L, Thomson D, Van Aken H, eds. Baillière's Clinical Anaesthesiology, vol. 7, no. 3, London: Baillière Tindall, 1993: 597-614.
120. Hua X-Y, Boublik JH, Spicer MA, Rivier JE, Brown MR, and Yaksh TL. The antinociceptive effects of spinally administered neuropeptide Y in the rat: Systematicstudies on structure-activity relationship. J Pharmacol Exp Ther 1991: 258: 243-258
121. Wilson PR, Yaksh TL. Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 1978: 51: 323-330.
122. Sosnowski M, and Yaksh TL. The role of spinal and brainstem adenosine receptors in the modulation of the volumeevoked micturition reflex in the unanesthetized rat. Brain Res 1990: 515: 207-213.
123. Yaksh TL. Tolerance: Factors involved in changes in the dose-effect relationship with chronic drug exposure. In: Basbaum AI, Besson J-M, eds. Towards a New Pharmacotherapy of Pain, Dahlem Workshop Reports, John Wiley & Sons Ltd. 1991: 157-179.
124. Lobato RD, Madrid JL, Fatela LV, Sarabia R, Rivas JJ, Gozalo A. Intraventricular morphine for intractable cancer pain: rationale, methods, clinical results. Acta Anaesthesiol Scand, Suppl 1987: 85: 68-74.
125. Lazorthes Y. Intracerebroventricular administration of morphine for control of irreducible cancer pain. Ann N Y Acad Sci 1988: 531: 123-132.
126. Lenzi A, Galli G, Gandolfini M, Marini G. Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. Neurosurgery 1985: 17: 6-11.
127. Lazorthes Y, Verdie JC, Caute B, Maranhao R, Tafani M. Intracerebroventricular morphinotherapy for control of chronic cancer pain. Prog Brain Res 1988: 77: 395-405.
128. Sandouk P, Serrie A, Urtizberea M, Debray M, Got P, Scherrmann JM. Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer. Clin Pharmacol Ther 1991: 49: 442-448.
129. Tafani JA, Lazorthes Y, Danet B, Verdie JC, Esquerre JP, Simon J, Guiraud R. Human brain and spinal cord scan after intracerebroventricular administration of iodine-123 morphine. International Journal of Radiation Applications and Instrumentation. Part B. Nucl Med Biol 1989: 16: 505-509.
130. Herz A, Tescehmacher H. Activities and sites of antinociceptive action of morphine-like analgesics and kinetics of redistribution following intravenous, intracerebral and intraventricular application. Adv Drug Res 1971: 6: 79-119.
131. Foley KM, Kourides IA, Inturrisi CE, Kaiko RF, Zaroulis CG, Posner JB, Houde RW, Li CH. Beta-endorphin: analgesic and hormonal effects in humans. Proc Natl Acad Sci USA: 1979: 76: 5377-5381.
132. Yaksh TL. Spinal opiates: a review of their effect on spinal function with emphasis on pain processing. Acta Anaesthesiol Scand 1987: 31: 25-37.
133. Behar M, Magora F, Olshwang D, Davidson JT. Epidural morphine in treatment of pain. Lancet 1979: 1: 527-529.
134. Magora F, Olshwang D, Eimerl D, Shorr J, Katzenelson R, Cotev S, Davidson JT. Observations on extradural morphine analgesia in various pain conditions. Br J Anaesth 1980: 52: 247-252.
135. Bromage PR, Camporesi E, Leslie J. Epidural narcotics in volunteers: sensitivity to pain and to carbon dioxide. Pain 1980: 9: 145-160.
136. Rawal N, Mollefors K, Axelsson K, Lingardh G, Widman B. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal. Anesth Analg 1983: 62: 641-647.
137. Onofrio BM, Yaksh TL. Intrathecal delta-receptor ligand produces analgesia in man. Lancet 1983: 1: 386-1387.
138. Stein C, Comisel K, Haimerl E, Yassouridis A, Lehrberger K, Herz A, Peter K. Analgesic effect of intra-articular morphine after arthroscopic knee surgery. N Engl J Med 1991: 325: 1123-1126.
139. Khoury GF, Chen ACN, Garland DE, Stein C. Intra-articular morphine, bupivacaine, and morphine/bupivacaine for pain control after knee videoarthroscopy. Anesthesiology 1992: 7: 263-266.
140. Haynes TK, Appadurai IR, Power I, Rosen M, Grant A. Intra-articular morphine and bupivacaine analgesia after arthroscopic knee surgery. Anaesthesia 1994: 49: 54-56.
141. Handwerker HO, Reeh PW: Pain and inflammation, Proceedings of the VIth World Congress on Pain. Bond MR, Harlton JE, Woolf CJ, eds. Elsevier Science Publishers BV 1991: 59-70.
142. Schaible H-G, Grubb BD. Afferent and spinal mechanism of joint pain. Pain 1993: 55: 5-54.
143. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988: 33: 87-107.
144. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992: 50: 355-363.
145. Yamamoto T, and Yaksh TL. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors. Anesthesiology 1991: 75: 817-826.
146. Lee Y-W, Chaplan S, Yaksh TL. Systemic and supraspinal, but not spinal opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 1995: 186: 111-114.
147. Arner S, Meyerson BA. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988: 33: 11-23.
148. Kenner DJ. Pain forum. Part 2. Neuropathic pain. Austral Fam Physician 1994: 23: 1279-1283.
149. Cherny NI, Thaler HT, Friedlander-Klar H, Lapin J, Foley KM, Houde R, Portenoy RK. Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology 1994: 44: 857-861.
150. Mjanger E, and Yaksh TL. Characteristics of dose-dependent antagonism by ß-funaltrexamine of the antinociceptive effects of intrathecal mu agonists. J Pharmacol Exp Ther 1991: 258: 544-550.
151. Adams JU, Paronis, CA and Holtzman SG. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine. J Pharmacol Exp Ther 1990: 255: 1027-1032.
152. Saeki S, Yaksh TL. Suppression of nociceptive responses by spinal mu opioid agonists: Effects of stimulus intensity and agonist efficacy. Anesth Analg 1993: 7: 265-274.
153. Saeki S, and Yaksh TL. Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli. J Pharmacol Exp Ther 1992: 260: 795-802.
154. Dirig DM, Yaksh TL. Differential right shifts in the dose response curves for intrathecal morphine and sufentanil as a function of stimulus intensity. Pain 1995: 62: 321-328.
155. Smith DJ, Perrotti JM, Crisp T, Cabrai ME, Long JT, Scalzitti JM. The mu opiate receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain. Eur J Pharmacol 1988: 156: 47-54.
156. Sanchez-Blazquez P, Garzon J. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect. Eur J Pharmacol 1989: 159: 9-23.
157. Drower EJ, Stapelfeld A, Rafferty MF, de Costa BR, Rice KC, Hammond DL. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic [D-penicillamine 2-D-penicillamine5] enkephalin in the rat. J Pharmacol Exp Ther 1991: 259: 725-731.
158. Yaksh TL, Noueihed RY, Durant PAC. Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in rat and cat. Anesthesiology 1986: 64: 54-66.
159. Oliveras J-L, Maixner W, Dubner R, Bushnell MC, Duncan G, Thomas DA, Bates R. Dorsal horn opiate administration attenuates the perceived intensity of noxious heat stimulation in behaving monkey. Brain Res 1986: 371: 368-371.
160. Taiwo YO, Coderre TJ, Levine JD. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res 1989: 487: 148-151.
161. Ness TJ, Gebhart GF. Differential effects of morphine and clonidine on visceral and cutaneous spinal nociceptive transmission in the rat. J Neurophysiol 1989: 62: 220-230.
162. Harada Y, Nishioka K, Kitahata LM, Nakatani K, Collins JG. Contrasting actions of intrathecal U50,488H, morphine, or [D-Pen2, D-Pen5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat. Anesthesiology 1995: 83 336-343.
163. Tang AH, Schoenfeld MJ. Comparison of subcutaneous and spinal subarachnoid injections of morphine and naloxone of analgesic tests in the rat. Eur J Pharmacol 1978: 52: 215-223.
164. Yamamoto T, and Yaksh TL. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 1992: 77: 757-763.
165. Wiesenfeld-Hallin Z. The effects of intrathecal morphine and naltrexone on autotomy in sciatic nerve sectioned rats. Pain 1984: 18: 267-278.
166. Yaksh TL. Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: Effects of modulatory receptor systems and excitatory amino acid antagonists. Pain 1989: 37: 111-123.
167. Van den Abeele G, Camu F. Clinical evaluation of the analgesic potency of lofentanil in postoperative pain. Acta Anaesthesiol Belg 1983: 34: 41-47.
168. Simpson KH, Madej TH, McDowell JM, MacDonald R, Lyons G. Comparison of extradural buprenorphine and extradural morphine after caesarean section. Br J Anaesth 1988: 60: 627-31.
169. Welchew EA. The optimum concentration for epidural fentanyl. A randomised, double-blind comparison with and without 1:200 000 adrenaline. Anaesthesia 1983: 338: 1037-1041.
170. Geller E, Chrubasik J, Graf R, Chrubasik S, Schulte-Monting J.A. Randomized double-blind comparison of epidural sufentanil versus intravenous sufentanil or epidural fentanyl analgesia after major abdominal surgery. Anesth Analg 1993: 76: 1243-250.
171. Brose WG, Tanelian DL, Brodsky JB, Mark JB, Cousins MJ. CSF and blood pharmakinetics of hydromorphone and morphine following lumbar epidural administration. Pain 1991: 45: 11-15.
172. Chauvin M, Salbaing J, Perrin D, Levron JC, Viars P. Clinical assessment and plasma pharmacokinetics associated with intramuscular or extradural alfentanil. Brit J Anaesth 1985: 57: 886-891.
173. Camann WR, Loferski BL, Fanciullo GJ, Stone ML, Datta S. Does epidural administration of butorphanol offer any clinical advantage over the intravenous route? A double-blind, placebo-controlled trial. Anesthesiology 1992: 76: 216-220.
174. Moulin DE, Max MB, Kaiko RF, Inturrisi CE, Maggard J, Yaksh TL, Foley KM. The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic pain. Pain 1985: 23: 213-221.
175. Oyama T, Fukushi S, Jin T. Epidural β-endorphin in treatment of pain. Can Anaesth Soc J 1982: 29: 24-26.
176. Torda TA, Pybus DA. Comparison of four narcotic analgesics for extradural analgesia. Br J Anaesth 1982: 54: 291-295.
177. Evron S, Samueloff A, Simon A, Drenger B, Magora F. Urinary function during epidural analgesia with methadone and morphine in postcesarean section patients. Pain 1985: 23: 135-144.
178. Xu XJ, Hao JX, Aldskogius H, Seiger A,Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain 1992: 48: 279-290.
179. Puke MJ, Wiesenfeld-Hallin Z. The differential effects of morphine and the alpha-2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain. Anesth Analg 1993: 77: 104-109.
180. Yamamoto T, Mizuguchi T. Time-dependent effects of oral morphine on autotomy following brachial nerve section in the rat. Neurosci Lett 1992: 141: 166-168.
181. Olshwang D, Shapiro A, Perlberg S, Magora F. The effect of epidural morphine on ureteral colic and spasm of the bladder. Pain 1984: 18: 97-101.
182. Bodnar RJ, Williams CL, Lee SJ, Pasternak GW. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Brain Res 1988: 447: 25-34.
183. Kuraishi Y, Hirota N, Satoh M, Takagi H. Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests. Brain Res 1985: 326: 168-171.